Xarelto Makers Withhold Information from Medical Journal?
Attorneys who are representing patients in lawsuits against two big drug markets are claiming that the makers of these drugs withheld important information from a leading medical journal. The companies, Johnson & Johnson and Bayer, are being called out by legal professionals because of an analysis performed by Duke researchers in which lawyers felt that key information that may have affected the clinical trials was left out.
A device that was used to test Xarelto’s effectiveness on blood clotting was recalled after concerns over the clinical trial’s faulty information to make the drug look more effective than warfarin.
Duke’s Clinical Research Institute ran their trial for three years using more than 14,000 patients and eventually led to FDA’s approval of Xarelto. They later reanalyzed results after the concerns were brought up regarding the faulty device. According to The New York Times, in the follow-up analysis, additional information was withheld that should have been published.
The medical journal that published the analysis claimed that they were unaware of additional lab data of roughly 5,000 blood samples that were sent to a central laboratory. The missing data raises some questions regarding whether the makers of the drug were hiding something about the blood-thinning drug.
Over the years, Xarelto has been linked to numerous side effects, including back pain, leg weakness, headaches, dizziness, and even paralysis. If you or someone you love is taking Xarelto and experiencing serious side effects, you may have a right to file a claim.
At Bailey Cowan Heckaman PLLC, we know how important it is for drug makers to make a safe prescription for patients. If they fail in this duty, they should be held accountable for their actions. If you believe you have a case, contact our firm today to discuss a potential lawsuit with our dangerous drug attorneys. We’re ready to help you!